Cargando…
miRNA-Based Technologies in Cancer Therapy
The discovery of therapeutic miRNAs is one of the most exciting challenges for pharmaceutical companies. Since the first miRNA was discovered in 1993, our knowledge of miRNA biology has grown considerably. Many studies have demonstrated that miRNA expression is dysregulated in many diseases, making...
Autores principales: | Pagoni, Maria, Cava, Claudia, Sideris, Diamantis C., Avgeris, Margaritis, Zoumpourlis, Vassilios, Michalopoulos, Ioannis, Drakoulis, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672431/ https://www.ncbi.nlm.nih.gov/pubmed/38003902 http://dx.doi.org/10.3390/jpm13111586 |
Ejemplares similares
-
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2023) -
First Trimester Maternal Plasma Aberrant miRNA Expression Associated with Spontaneous Preterm Birth
por: Mavreli, Danai, et al.
Publicado: (2022) -
Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients
por: Avgeris, Margaritis, et al.
Publicado: (2018) -
miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy
por: Thomaidou, Arsinoe C., et al.
Publicado: (2023) -
Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
por: Santo, Giulia Dal, et al.
Publicado: (2022)